A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia
Clinical trial NCT02930109 · COMPLETED
Trial details
- NCT number
- NCT02930109
- Sponsor
- Prescient Therapeutics, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-09
- Primary completion
- 2023-10-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.